1988
DOI: 10.1159/000205752
|View full text |Cite
|
Sign up to set email alerts
|

Adult Leukemia Developing after Aplastic Anemia: Report of 8 Cases

Abstract: 481 cases of adult leukemia (115 acute lymphoblastic leukemia, ALL, and 366 acute nonlymphoid leukemia, ANLL) diagnosed at the Hematology Division of Pavia between 1976 and 1985 were reviewed to evaluate how many patients had an aplastic presentation. In 8 cases (1.6%) typical marrow hypoplasia preceded overt leukemia. At the leukemic transformation, the morphological and immunological findings were diagnostic for non-T non-B ALL in 2 cases, for ANLL in 5 cases (2 M1, 2 M2, 1 M5) and for Ph’-negative chronic g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1990
1990
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 11 publications
0
4
0
Order By: Relevance
“…The aetiology of most cases of aplastic anaemia (AA) is unknown. Data are now available that indicate, in some cases, that AA should be considered as a preleukaemic state: (i) AA may reveal a clonal haematopoietic disorder such as paroxysmal nocturnal haemoglobinuria (PNH) (Tooze et al , 1999); (ii) patients treated for AA may develop myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML) after immunosuppressive therapy (De Planque et al , 1989; Socié et al , 1993); (iii) a transient phase of AA may precede acute lymphoblastic leukaemia (ALL) in childhood (Breatnach et al , 1981; Matloub et al , 1993; Liang et al , 1994; Hasle et al , 1995) and, in a very few cases, in adults (Nakamori et al , 1986; Orlandi et al , 1988). Data concerning cytogenetic abnormalities in these cases of AA or in primary acquired AA are scarce.…”
mentioning
confidence: 99%
“…The aetiology of most cases of aplastic anaemia (AA) is unknown. Data are now available that indicate, in some cases, that AA should be considered as a preleukaemic state: (i) AA may reveal a clonal haematopoietic disorder such as paroxysmal nocturnal haemoglobinuria (PNH) (Tooze et al , 1999); (ii) patients treated for AA may develop myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML) after immunosuppressive therapy (De Planque et al , 1989; Socié et al , 1993); (iii) a transient phase of AA may precede acute lymphoblastic leukaemia (ALL) in childhood (Breatnach et al , 1981; Matloub et al , 1993; Liang et al , 1994; Hasle et al , 1995) and, in a very few cases, in adults (Nakamori et al , 1986; Orlandi et al , 1988). Data concerning cytogenetic abnormalities in these cases of AA or in primary acquired AA are scarce.…”
mentioning
confidence: 99%
“…Examples are numerous. For instance, myelodysplas c syndromes (MDS) o en precede by years (some mes by decades) the development of overt leukemia [1181,1182]. MDS by itself may cause poten ally life-threatening symptoms (anemia, thrombocytopenia, agranulocytopenia, etc.).…”
Section: Faith Baldwin (1893-1978)mentioning
confidence: 99%
“…examples are numerous. it is well known from clinical practice that myelodysplastic syndromes (MDS) often precede (sometimes by decades) the development of overt leukemia (59,78). Myelodysplasias may produce potentially life-threatening incidents on their own (e.g.…”
Section: Back In My Day We Didn't Have This: the Emergence Of Aging-rmentioning
confidence: 99%